Friday December 13, 2019
Home India Delhi HC Dism...

Delhi HC Dismisses Plea Seeking Direction to Media to Use Word ‘Martyr’

Abhishek Chaudhary urged the court to direct the media to use the word "martyr" as "brave soldiers are never killed."

0
//
Delhi High Court. Image source: Flickr

The Delhi High Court on Tuesday dismissed a plea seeking direction to the media to use the word “martyr” in place of killed and died for soldiers.

The bench comprising Chief Justice Rajendra Menon and Justice V. Kameswar Rao also slammed the petitioner and advocate Abhishek Choudhury for filing the frivolous application on the same ground which was already disposed off by another bench in October 2016.

Pulwama, Kashmir, Delhi HC
The plea was filed after 40 CRPF troopers were killed in a terror attack in Pulwama in Jammu and Kashmir on February 14. newsx.com

Choudhury has filed the plea seeking direction to the press and electronic media to use “respectful words on the martyrdom of soldiers”.

ALSO READ: Indian Army Kills JeM Operational Commander Within 100 hours of Pulwama Attack

He urged the court to direct the media to use the word “martyr” as “brave soldiers are never killed.”

The plea was filed after 40 CRPF troopers were killed in a terror attack in Pulwama in Jammu and Kashmir on February 14. (IANS)

Next Story

Delhi High Court Directs Private Clinic to Continue with the Stem Cell Treatment

The clinic, which is administering the medicine, cannot function under the new rules until the licence is duly obtained

0
Order
Delhi High Court. Source- Wikimedia

In an interim relief, the Delhi High Court has directed a private clinic to continue with the stem cell treatment being provided to the patients till its further orders.

The court’s interim direction came while hearing various petitions challenging the Centre’s decision to put stem cell therapy in the category of new drugs.

The petitioners were being provided stem cell treatment in Nutech Mediworld Clinic in Green Park here.

A Division Bench of justices Anu Malhotra and Talwant Singh said that all details of treatment being provided to the petitioners by the clinic be placed on record with an affidavit.

Representational image.

The court has sought the response of Centre and Indian Council of Medical Research to file reply on the petition and listed the matter for September 4 for further hearing.

The court has directed authorities concerned to examine whether the products being administered to the petitioners, prima facie, fall within the scope of the expression ‘new drugs’ as defined under Rule 2(1) (w) of New Drugs and Clinical Trial Rules, 2019 and communicate the view to the petitioners and the said clinic.

Also Read- LG CNS, Microsoft to Develop Cloud-based Enterprise Solutions

On account of the Centre’s fresh notification on ‘New Drugs and Clinical Rule 2019’, some medications used for the treatment would fall under the definition of ‘new drug’ and require approval from the authority concerned.

The clinic, which is administering the medicine, cannot function under the new rules until the licence is duly obtained. (IANS)